Cytokinetics (CYTK) Shares Issued: 2009-2025
Historic Shares Issued for Cytokinetics (CYTK) over the last 11 years, with Sep 2025 value amounting to $6.9 million.
- Cytokinetics' Shares Issued was N/A to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.3 million, marking a year-over-year change of. This contributed to the annual value of $53.0 million for FY2024, which is 187.21% up from last year.
- Latest data reveals that Cytokinetics reported Shares Issued of $6.9 million as of Q3 2025, which was up 2.82% from $6.7 million recorded in Q2 2025.
- Cytokinetics' Shares Issued's 5-year high stood at $93.6 million during Q1 2024, with a 5-year trough of -$43.6 million in Q2 2024.
- Moreover, its 3-year median value for Shares Issued was $5.9 million (2023), whereas its average is $9.3 million.
- Over the last 5 years, Cytokinetics' Shares Issued had its largest YoY gain of 2,539.98% in 2024, and its largest YoY loss of 867.36% in 2024.
- Cytokinetics' Shares Issued (Quarterly) stood at $15.1 million in 2021, then plummeted by 76.24% to $3.6 million in 2022, then surged by 69.57% to $6.1 million in 2023, then crashed by 50.57% to $3.0 million in 2024, then spiked by 115.46% to $6.9 million in 2025.
- Its Shares Issued was $6.9 million in Q3 2025, compared to $6.7 million in Q2 2025 and $7.7 million in Q1 2025.